Monica Dinulescu Selected Research

N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamide

1/2021	Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors.
1/2021	Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica Dinulescu Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 01/2017
4	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2021 - 10/2020
1	Dysbiosis 01/2022
1	Merkel Cell Carcinoma 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2021
1	Fatigue 01/2021
1	Diarrhea 01/2021
1	Asthenia 01/2021
1	Edema (Dropsy) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2020
1	Skin Diseases (Skin Disease) 02/2017
1	Drug Hypersensitivity Syndrome 09/2012

Drug/Important Bio-Agent (IBA)

2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2021
2	N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA 01/2021 - 01/2021
2	pembrolizumabIBA 10/2020 - 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	cemiplimabIBA 07/2021
1	AntibodiesIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	LigandsIBA 10/2020
1	IpilimumabIBA 01/2020
1	NivolumabIBA 01/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 09/2012

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2017
2	Immunotherapy 01/2022 - 01/2020
1	Drug Therapy (Chemotherapy) 10/2020
1	Lasers (Laser) 02/2017